Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

172 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CECs and IL-8 Have Prognostic and Predictive Utility in Patients with Recurrent Platinum-Sensitive Ovarian Cancer: Biomarker Correlates from the Randomized Phase-2 Trial of Olaparib and Cediranib Compared with Olaparib in Recurrent Platinum-Sensitive Ovarian Cancer.
Lee JM, Trepel JB, Choyke P, Cao L, Sissung T, Houston N, Yu M, Figg WD, Turkbey IB, Steinberg SM, Lee MJ, Ivy SP, Liu JF, Matulonis UA, Kohn EC. Lee JM, et al. Among authors: ivy sp. Front Oncol. 2015 Jun 1;5:123. doi: 10.3389/fonc.2015.00123. eCollection 2015. Front Oncol. 2015. PMID: 26082895 Free PMC article.
Radiopharmaceuticals for Relapsed or Refractory Leukemias.
Kunos CA, Capala J, Ivy SP. Kunos CA, et al. Among authors: ivy sp. Front Oncol. 2019 Feb 25;9:97. doi: 10.3389/fonc.2019.00097. eCollection 2019. Front Oncol. 2019. PMID: 30859091 Free PMC article.
Radiopharmaceuticals for Relapsed or Refractory Ovarian Cancers.
Kunos CA, Capala J, Finnigan S, Smith GL, Ivy SP. Kunos CA, et al. Among authors: ivy sp. Front Oncol. 2019 Mar 26;9:180. doi: 10.3389/fonc.2019.00180. eCollection 2019. Front Oncol. 2019. PMID: 30984615 Free PMC article.
172 results